A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: A Southwest Oncology Group Study

Author： Whitehead Robert   Benedetti Jacqueline   Abbruzzese James   Ardalan Bach   Goodwin J.   Balcerzak Stanley   Samlowski Wolfram   Lenz Heinz-Josef   Macdonald John  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.22, Iss.3, 2004-08, pp. : 335-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Single Center Phase II Study of Continuous Infusion of Low-dose 5- fluorouracil for Heavily Pretreated Patients With Metastatic Colorectal Cancer

By  

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 87-90

Bentham Science Publishers

Access to resources Recommend Favorite

A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers

By Ciuleanu T.   Diculescu M.   Hoepffner N.   Trojan J.   Sailer V.   Zalupski M.   Herrmann T.   Roth A.   Chick J.   Brock K.   Albert D.   Philip P.  

Investigational New Drugs, Vol. 25, Iss. 4, 2007-08 ,pp. : 385-390

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study

By Whitehead Robert   McCoy Sheryl   Macdonald John   Rivkin Saul   Neubauer Marcus   Dakhil Shaker   Lenz Heinz-Josef   Tanaka Michael   Abbruzzese James  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 335-341

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: A Southwest oncology group (SWOG 9924) study

By Macdonald John   McCoy Sheryl   Whitehead Robert   Iqbal Syma   Wade James   Giguere Jeffrey   Abbruzzese James  

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 485-487

Springer Publishing Company

Access to resources Recommend Favorite

Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study

By Tsavaris Nicolas   Kosmas Christos   Skopelitis Helias   Gouveris Panagiotis   Kopteridis Petros   Loukeris Dioynissis   Sigala Frantzeska   Zorbala-Sypsa Alexandra   Felekouras Evangelos   Papalambros Efstathios  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 369-375

Springer Publishing Company

Access to resources Recommend Favorite